Related Experiment Video
Updated: Apr 27, 2026

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
Published on: August 25, 2022
Sterile product compounding using an i.v. compounding workflow management system at a pediatric hospital
Thomas T Moniz1, Stephen Chu2, Crystal Tom2
1Thomas T. Moniz, Pharm.D., is Informatics Pharmacist, Department of Pharmacy, Boston Children's Hospital, Boston, MA. Stephen Chu, Pharm.D., is Clinical Pediatric Pharmacist, Department of Pharmacy, Boston Children's Hospital, and Adjunct Professor, MCPHS University School of Pharmacy-Boston. Crystal Tom, Pharm.D., BCPS, is General Pediatrics Pharmacist Team Lead, Department of Pharmacy, Boston Children's Hospital, and Adjunct Professor, Bouvé College of Health Sciences School of Pharmacy, Northeastern University, Boston, and MCPHS University School of Pharmacy-Boston. Peter Lutz, Pharm.D., is Associate Director of Pharmacy, Department of Pharmacy, Boston Children's Hospital, and Adjunct Professor, Bouvé College of Health Sciences School of Pharmacy, Northeastern University, and MCPHS University School of Pharmacy-Boston. Alana Arnold, Pharm.D., BCPS, AQ-ID, is Associate Director of Pharmacy, Boston Children's Hospital, and Adjunct Professor, Bouvé College of Health Sciences School of Pharmacy, Northeastern University, and MCPHS University School of Pharmacy-Boston. Kathleen M. Gura, Pharm.D., BCNSP, FASHP, FPPAG, is Team Leader, Surgical Program, and Clinical Pharmacy Specialist in Gastroenterology/Nutrition, Boston Children's Hospital, and Adjunct Professor, Bouvé College of Health Sciences School of Pharmacy, Northeastern University, and MCPHS University School of Pharmacy-Boston. Al Patterson, Pharm.D., is Director of Pharmacy, Boston Children's Hospital, and Adjunct Professor, Bouvé College of Health Sciences School of Pharmacy, Northeastern University, and MCPHS University School of Pharmacy-Boston. thomas.moniz@childrens.harvard.edu.
Purpose:
Patient safety enhancements achieved through the use of an automated i.v. compounding workflow management system are reported.
Summary:
Automated systems integrating barcode verification of ingredients and the capture of serial images of all steps of the admixture process have the potential to improve the accuracy of parenteral i.v. medication dose preparation. About 18 months after the implementation of such a system at a large pediatric hospital, a retrospective analysis of dose preparation outcomes was conducted to evaluate the effectiveness of the i.v. workflow manager in detecting compounding errors and to categorize detected errors. In verifying the accuracy of 425,683 medication doses prepared during the approximately 13-month evaluation period, dispensing pharmacists detected preparation or documentation errors affecting 2,900 doses (0.68%); 1,223 of those doses (0.29%) required reworking, and 1,677 (0.4%) were rejected and destroyed. Roughly 23% of the detected errors were classified as undetectable via the pharmacy's previous verification practices, with 167 errors judged to pose the potential for adverse drug events resulting in moderate (n=146) or severe (n=21) harm. Among the reworked and rejected doses, 43.8% and 31.3%, respectively, were due to newly emergent problems not seen with traditional paper-based verification systems; however, most of these errors involved blurry or missing images and were not judged to be clinically significant.
Conclusion:
Implementation of an i.v. workflow management system that integrates barcode verification, automated calculations, and image-capture capabilities led to increased detection of errors in the sterile product compounding process.
Related Concept Videos
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
One-Compartment Model: IV Infusion
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
IV Infusion to Oral Dosing: Conversion Methods
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...

